Dr. Andy Roberts, speaking March 11 at the National Horsemen's Benevolent and Protective Association's convention, said an out-of-competition rule approved by the Association of Racing Commissioners International could have unintended impact.
The Kentucky Equine Drug Research Council, on a 4-2 vote Dec. 3, recommended the Kentucky Horse Racing Commission adopt the national uniform medication rules for Thoroughbred racing.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A public hearing designed to gauge public opinion about a proposal to permit "Instant Racing" type wagering in Kentucky became a faceoff between representatives of the state's horse industry and the Family Foundation.
The Kentucky Horse Racing Authority, acting on advice from the Equine Drug Research Council, unanimously approved medication withdrawal guidelines and threshold levels at a special meeting Feb. 10.
Most Popular Stories
- Phipps, Gaines, Winn Named 2017 Pillars of the Turf
- Classic Empire to Coolmore on Retirement
- Leslie's Lady in Foal to American Pharoah
- Laurel Stakes Schedule Features $1.6 Million in Purses
- Curlin Colt Sets Midlantic Record at $1.5 Million
- Agent O'Neill Bullish on Stallion Orb
- Phipps Family to Receive Inaugural Dinny Phipps Award
- McCraken Back on Work Tab After Derby Disappointment
- Thunder Snow, Churchill Face Off in Irish 2,000 Guineas
- What's Going On Here: The Pay Off